These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2694817)

  • 1. Adenoviruses as vectors for the transfer of genetic information and for the construction of new type vaccines.
    Tikchonenko TI
    Adv Exp Med Biol; 1989; 257():193-204. PubMed ID: 2694817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus vectors as recombinant viral vaccines.
    Imler JL
    Vaccine; 1995 Sep; 13(13):1143-51. PubMed ID: 8578797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
    Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of nonhuman adenoviruses as vaccine vectors.
    Bangari DS; Mittal SK
    Vaccine; 2006 Feb; 24(7):849-62. PubMed ID: 16297508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-based expression vectors and recombinant vaccines.
    Graham FL; Prevec L
    Biotechnology; 1992; 20():363-90. PubMed ID: 1318139
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenoviruses as vaccine vectors.
    Tatsis N; Ertl HC
    Mol Ther; 2004 Oct; 10(4):616-29. PubMed ID: 15451446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
    Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
    Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
    Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant adenoviruses as vaccines.
    Randrianarison-Jewtoukoff V; Perricaudet M
    Biologicals; 1995 Jun; 23(2):145-57. PubMed ID: 7546657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors.
    Abbink P; Maxfield LF; Ng'ang'a D; Borducchi EN; Iampietro MJ; Bricault CA; Teigler JE; Blackmore S; Parenteau L; Wagh K; Handley SA; Zhao G; Virgin HW; Korber B; Barouch DH
    J Virol; 2015 Feb; 89(3):1512-22. PubMed ID: 25410856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell immunity generated by recombinant adenovirus vaccines.
    Yang TC; Millar JB; Grinshtein N; Bassett J; Finn J; Bramson JL
    Expert Rev Vaccines; 2007 Jun; 6(3):347-56. PubMed ID: 17542750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviruses as expression vectors and recombinant vaccines.
    Graham FL
    Trends Biotechnol; 1990 Apr; 8(4):85-7. PubMed ID: 1366528
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
    Alcock R; Cottingham MG; Rollier CS; Furze J; De Costa SD; Hanlon M; Spencer AJ; Honeycutt JD; Wyllie DH; Gilbert SC; Bregu M; Hill AV
    Sci Transl Med; 2010 Feb; 2(19):19ra12. PubMed ID: 20371486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccines.
    Hung PP; Chanda PK; Natuk RJ; Mason BB; Chengalvala M; Bhat BM; Molnar-Kimber KL; Dheer SK; Morin JE; Mizutani S
    Nat Immun Cell Growth Regul; 1990; 9(3):160-4. PubMed ID: 2196459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective adenoviruses as virus vectors for veterinary vaccines.
    Eloit M
    Vet Res; 1995; 26(3):207-8. PubMed ID: 7795677
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved vascular gene transfer with a helper-dependent adenoviral vector.
    Wen S; Graf S; Massey PG; Dichek DA
    Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements in gene therapy: averting the immune response to adenoviral vectors.
    Ritter T; Lehmann M; Volk HD
    BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
    Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
    J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral vectors as vaccine carriers.
    Ertl HC
    Curr Opin Virol; 2016 Dec; 21():1-8. PubMed ID: 27327517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.